Triple-negative breast cancer (TNBC) accounts for 10–20% of primary breast cancers that lack expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [1]. This evidence concerns the gene ERBB2 and breast carcinoma.